PROVENGE UPDATE – DEMAND A COMPASSIONATE USE PROGRAM

Dendreon Corp. has received great news from the FDA about their pending application for the approval of Provenge. STILL TIME TO SIGN PATIENT PETITION TO FDA FOR PROSTATE CANCER TREATMENT APPROVAL and Provengenow news-- Click Here NEW YORK (Dow Jones)--Dendreon Corp. (DNDN) Thursday said the Food and Drug Administration would accept interim trial data to [...]

Support Men with Prostate Cancer

There are three more day's to put your name forward and sign up to show your support for men with advanced prostate cancer. Even though the Food and Drug Administration is a United States Government agency, it's decisions affect prostate cancer treatment throughout the world. Dr George Cooper has written an excellent letter of understanding [...]

Go to Top